MidFirst Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
MidFirst Bank's REGN Position: Q2 2026 in Review
MidFirst Bank increased its Regeneron Pharmaceuticals (REGN) stake by 2.1% in Q2 2026, buying an estimated $1.36K and bringing the position to 98 shares worth $61.1K. The position accounts for ﹤0.01% of the portfolio, ranked #377.
MidFirst Bank first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $74.2K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- MidFirst Bank held 98 shares of Regeneron Pharmaceuticals worth $61.1K as of Q2 2026.
- MidFirst Bank bought 2 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.36K.
- Regeneron Pharmaceuticals made up ﹤0.01% of MidFirst Bank's portfolio in Q2 2026, its #377 holding.
- MidFirst Bank first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- MidFirst Bank's Regeneron Pharmaceuticals position peaked at $74.2K in Q1 2026.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.